In addition, loss[8p] and copy number gain of MCL1, an anti-apoptotic member alternative to Bcl-2, have been identified as potentially genes-first mechanisms of acquired venetoclax resistance in CLL [64]. The gene discussed is MCL1; the disease is B-cell chronic lymphocytic leukemia.